The fourth Strategies for Engineered Negligible Senescence (SENS) Conference is currently underway at Queens' College, Cambridge, England. The meeting brings together experts in the antiaging research and medical communities under a common banner: to expedite the development of truly effective therapies to postpone and treat human aging.

The solution, they say, is to tackle antiaging as an engineering problem. In other words, an important goal is to enumerate the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair — reverse — those changes, rather than merely to slow down their further accumulation.

The home page for the SENS4 conference is here. A complete listing of all the conference abstracts is here.